Product
meta-iodobenzylguanidine (MIBG)
1 clinical trial
5 indications
Indication
Lewy Body DiseaseIndication
DementiaIndication
Parkinson's diseaseIndication
Mild Cognitive ImpairmentIndication
REM Sleep Behavior DisorderClinical trial
Myocardial 123I-MIBG Scintigraphy in Aging and Neurodegenerative DiseaseStatus: , Estimated PCD: 2025-09-01